FIELD: organic chemistry, medicine, oncology, pharmacy.
SUBSTANCE: invention relates to a novel synthesis of compound of the formula (5) representing a key intermediate compound in synthesis of strong anti-tumor agent ectenascidine 743 of the formula (1) and phthalascidine of the formula (2) and easily available intermediate compounds of formulae (3) and (4) . Invention provides simplifying process.
EFFECT: improved method for synthesis.
26 cl, 16 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS OF SYNTHESIS OF ESTEINASCIDINE, COMPOUNDS, INTERMEDIATE SUBSTANCE | 1997 |
|
RU2194709C2 |
SYNTHESIS OF 4-ALPHA-ARYLEPICATECHINS AND INTERMEDIATE SUBSTANCES | 2001 |
|
RU2281942C2 |
VITAMIN D PRECURSORS, METHOD FOR PREPARATION THEREOF, AND INTERMEDIATES | 2000 |
|
RU2247710C2 |
CASPASE INHIBITORS | 1999 |
|
RU2274642C2 |
SUBSTITUTED 4-ARYL-HEXAHYDRO-7H-IMIDAZOLO[1,5-B][1,2]OXAZINE-7-ONES AND METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2670097C1 |
PROCESS FOR THE PREPARATION OF (6R,7S,7AS)-6-((R)-1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHOXY)-7-(4-FLUOROPHENYL)HEXAHYDRO-3H-PYRROLISIN-3-ONE | 2022 |
|
RU2789599C1 |
AGONISTS OF RECEPTOR OF PEPTIDE-1, SIMILAR TO GLUCAGONE, THEIR OBTAINING AND APPLICATION | 2003 |
|
RU2342368C2 |
WATER-SOLUBLE PHENYLPYRIDAZINE DERIVATIVES AND THERAPEUTICAL AGENTS CONTAINING THEM | 2002 |
|
RU2302413C2 |
ALKYNYL INDAZOLE DERIVATIVE AND USE THEREOF | 2015 |
|
RU2667486C2 |
INHIBITORS OF HIV INTEGRASE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 2002 |
|
RU2284315C2 |
Authors
Dates
2006-01-10—Published
2001-02-09—Filed